Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 1
1992 1
1998 1
1999 1
2002 2
2003 2
2005 1
2006 1
2007 3
2008 3
2009 6
2010 2
2011 8
2012 10
2013 9
2014 8
2015 9
2016 15
2017 6
2018 8
2019 5
2020 5
2021 8
2022 6
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bièche I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, André F. Mosele F, et al. Among authors: bonastre j. Ann Oncol. 2020 Nov;31(11):1491-1505. doi: 10.1016/j.annonc.2020.07.014. Epub 2020 Aug 24. Ann Oncol. 2020. PMID: 32853681 Free article. Review.
[Editorial].
Perrier L; French Costing Group. Perrier L, et al. Rev Epidemiol Sante Publique. 2018 Mar;66 Suppl 2:S63-S64. doi: 10.1016/j.respe.2018.02.004. Epub 2018 Feb 24. Rev Epidemiol Sante Publique. 2018. PMID: 29487012 French. No abstract available.
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group.
Mosele MF, Westphalen CB, Stenzinger A, Barlesi F, Bayle A, Bièche I, Bonastre J, Castro E, Dienstmann R, Krämer A, Czarnecka AM, Meric-Bernstam F, Michiels S, Miller R, Normanno N, Reis-Filho J, Remon J, Robson M, Rouleau E, Scarpa A, Serrano C, Mateo J, André F. Mosele MF, et al. Among authors: bonastre j. Ann Oncol. 2024 Jul;35(7):588-606. doi: 10.1016/j.annonc.2024.04.005. Epub 2024 May 27. Ann Oncol. 2024. PMID: 38834388 Free article.
Patient-reported measures: how useful in health economics?
Le Corroller AG, Bonastre J. Le Corroller AG, et al. Among authors: bonastre j. Eur J Health Econ. 2023 Feb;24(1):1-4. doi: 10.1007/s10198-022-01524-z. Epub 2022 Nov 8. Eur J Health Econ. 2023. PMID: 36346476 No abstract available.
[Economic analysis of multinational clinical trials in oncology].
Lejeune C, Lueza B, Bonastre J; le French costing group. Lejeune C, et al. Among authors: bonastre j. Bull Cancer. 2018 Feb;105(2):204-211. doi: 10.1016/j.bulcan.2017.10.027. Epub 2018 Feb 21. Bull Cancer. 2018. PMID: 29397917 Review. French.
[Data sources, the data used, and the modality for collection].
Mercier G, Costa N, Dutot C, Riche VP; French Costing Group. Mercier G, et al. Rev Epidemiol Sante Publique. 2018 Mar;66 Suppl 2:S73-S91. doi: 10.1016/j.respe.2018.02.005. Epub 2018 Mar 9. Rev Epidemiol Sante Publique. 2018. PMID: 29530439 Review. French.
Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life.
Lebret T, Bonastre J, Fraslin A, Neuzillet Y, Droupy S, Rebillard X, Vordos D, Guy L, Villers A, Schneider M, Coloby P, Lacoste J, Méjean A, Lacoste J, Descotes JL, Eschwege P, Loison G, Blanché H, Mariani O, Ghaleh B, Mangin A, Sirab N, Groussard K, Radvanyi F, Allory Y, Benhamou S. Lebret T, et al. Among authors: bonastre j. BMJ Open. 2023 Dec 20;13(12):e075942. doi: 10.1136/bmjopen-2023-075942. BMJ Open. 2023. PMID: 38128940 Free PMC article.
117 results